Thursday, April 11, 2013
Pfizer's Bosutinib Receives Positive Opinion For Conditional Marketing ...
<strong>Pfizer's Bosutinib Receives Positive Opinion For Conditional Marketing ...</strong><br /><p>NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the conditional marketing authorization of ...<a
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment